Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
m 04:03 | Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →Malignant pleural mesothelioma |
m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma |
|
m 03:26 | Stub 2 changes history +16,468 [Jwarner (2×)] | |||
m |
|
03:26 (cur | prev) +504 Jwarner talk contribs →Regimens that contain experimental (unapproved) drugs | |||
m |
|
03:25 (cur | prev) +15,964 Jwarner talk contribs →Regimens composed solely of approved drugs |
28 May 2024
m 15:46 | Non-small cell lung cancer, nonsquamous diffhist +2,101 Jwarner talk contribs →Carboplatin & Paclitaxel (CP) & Bevacizumab {{#subobject:1c2c25|Regimen=1}} |
|
m 15:33 | Non-small cell lung cancer - null regimens 2 changes history +2,010 [Jwarner (2×)] | |||
m |
|
15:33 (cur | prev) +1,017 Jwarner talk contribs →Placebo | |||
m |
|
00:10 (cur | prev) +993 Jwarner talk contribs →Placebo |
m 00:17 | Non-small cell lung cancer, CNS metastases diffhist +718 Jwarner talk contribs →Whole brain irradiation {{#subobject:61gh5b|Regimen=1}} |